![]() |
|||
|
|
|
|
| UPDATE: May 2009 | MW: 430.79 | MF: C29H50O2 |
SYNONYMS:
|
|
| |
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
DNA adduct
|
intravenous | rat
27 nmol/kg
|
EXPEAM 31,1023,1975
|
DNA inhibition
|
rat
liver
|
100 µmol/L
|
CNREA8 45,337,1985
|
| |||
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
oral | human
lowest published toxic dose: 346.6 mg/kg (1-13 week pregnant)
|
Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain)
|
REPTED 20,85,2005
|
oral | rat
lowest published toxic dose: 7,500 mg/kg (1-20 day pregnant)
|
Reproductive: Effects on fertility: Other measures of fertility
|
NYKZAU 69,293,1973
|
oral | rat
lowest published toxic dose: 25,000 mg/kg (1-10 day pregnant)
|
Reproductive: Other effects to embryo or fetus
|
BDERE* 76,483,2006
|
| |||
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
| |||
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intramuscular | rat
lowest published toxic dose: 500 mg/kg
|
Brain and Coverings: Changes in surface EEG | Behavioral: Anticonvulsant
NRTXDN 28,463,2007
|
intraperitoneal | mouse
lowest published toxic dose: 10 mg/kg
|
Behavioral: Rigidity (includes catalepsy)
|
PSCHDL 181,71,2005
|
intraperitoneal | rat
lowest published toxic dose: 10 mg/kg
|
Liver: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Metabolism (intermediary): Lipids including transport
FATOAO 55,34,1992
|
intraperitoneal | rat
lowest published toxic dose: 600 mg/kg
|
Kidney, Ureter, and Bladder: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases
JAPTO* 25,8,2005
|
intraperitoneal | rat
lowest published toxic dose: 40 mg/kg
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Lipids including transport
TXCYAC 217,240,2006
|
intravenous | man
lowest published toxic dose: 257 µg/kg
|
Vascular: Other changes
|
CLPTAT 67,22,2000
|
intravenous | rat
lowest published toxic dose: 20 mg/kg
|
Cardiac: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Metabolism (intermediary): Lipids including transport
CEXPB9 30,745,2003
|
oral | mouse
lethal dose (50 percent kill): >25 mL/kg
|
N/R
|
IJTOFN 21,51,2002
|
oral | rat
lowest published toxic dose: 50 mg/kg
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
|
FATOAO 53,33,1990
|
oral | rat
lowest published toxic dose: 100 mg/kg
|
Gastrointestinal: Other changes
|
BPBLEO 29,675,2006
|
oral | rat
lowest published toxic dose: 250 mg/kg
|
Behavioral: Change in motor activity (specific assay) | Biochemical: Metabolism (intermediary): Lipids including transport
FCLPH* 17,703,2003
|
unreported route | rat
lowest published toxic dose: 50 mg/kg
|
Liver: Other changes | Biochemical: Metabolism (intermediary): Lipids including transport
EKFAE9 56,55,1993
|
| |||
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
intraperitoneal | mouse
lowest published toxic dose: 300 mg/kg/3 day- intermittent
|
Biochemical: Metabolism (intermediary): Other
|
TOXID9 44,45,2005
|
intraperitoneal | mouse
lowest published toxic dose: 300 mg/kg/3 day- intermittent
|
Behavioral: Convulsions or effect on seizure threshold
|
TOXID9 66,90,2002
|
intraperitoneal | mouse
lowest published toxic dose: 300 mg/kg/3 day- intermittent
|
Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
|
TOXID9 90,102,2006
|
intraperitoneal | rat
lowest published toxic dose: 20 mg/kg/2 day- intermittent
|
Lung, Thorax, or Respiration: Other changes | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
EJPHAZ 494,213,2004
|
intraperitoneal | rat
lowest published toxic dose: 560 mg/kg/28 day- intermittent
|
Kidney, Ureter, and Bladder: Other changes in urine composition | Kidney, Ureter, and Bladder: Other changes
BJMRDK 38,1043,2005
|
intraperitoneal | rat
: 45 mg/kg/3 day- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Hepatic microsomal mixed oxidase (dealkylation, hydroxylation, etc.) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
EJPHAZ 534,202,2006
|
intraperitoneal | rat
lowest published toxic dose: 10,000 mg/kg/5 day- intermittent
|
Brain and Coverings: Recordings from specific areas of CNS | Biochemical: Metabolism (intermediary): Other
NRTXDN 28,161,2007
|
intravenous | rat
lowest published toxic dose: 1,200 units/kg/6 week- intermittent
|
Cardiac: Other changes | Biochemical: Metabolism (intermediary): Lipids including transport
BJMRDK 35,1379,2002
|
intravenous | rat
lowest published toxic dose: 1,200 units/kg/6 week- intermittent
|
Liver: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Metabolism (intermediary): Lipids including transport
TXCYAC 209,39,2005
|
oral | mouse
lowest published toxic dose: 320 mg/kg/2 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases | Biochemical: Metabolism (intermediary): Lipids including transport
JOETD7 97,477,2005
|
oral | mouse
lowest published toxic dose: 800 mg/kg/5 day- intermittent
|
Behavioral: Alteration of classical conditioning
|
JOETD7 97,477,2005
|
oral | mouse
lowest published toxic dose: 3,500 mg/kg/10 week- intermittent
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Alteration of operant conditioning Immunological Including Allergic: Increase in cellular immune response
ACPSI* 24,230,2003
|
oral | mouse
lowest published toxic dose: 4,200 mg/kg/12 week- intermittent
|
Behavioral: Change in motor activity (specific assay) | Behavioral: Alteration of operant conditioning Immunological Including Allergic: Increase in cellular immune response
ACPSI* 24,230,2003
|
oral | mouse
lowest published toxic dose: 350 units/kg/10 week- intermittent
|
Cardiac: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases
INHTE5 15,513,2003
|
oral | rat
lowest published toxic dose: 39.7 gm/kg/13 week- continuous
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
|
FCTOD7 39,799,2001
|
oral | rat
lowest published toxic dose: 39.7 gm/kg/13 week- continuous
|
Liver: Changes in liver weight | Nutritional and Gross Metabolic: Changes in: Ca Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
FCTOD7 39,799,2001
|
oral | rat
lowest published toxic dose: 1,500 mg/kg/30 day- intermittent
|
Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count)
FCTOD7 42,1563,2004
|
oral | rat
lowest published toxic dose: 2,400 mg/kg/6 week- intermittent
|
Cardiac: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TXCYAC 202,227,2004
|
oral | rat
lowest published toxic dose: 9.24 units/kg/4 week- continuous
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases
TOXID9 1,48,2001
|
oral | rat
: 500 mg/kg/5 day- intermittent
|
Vascular: Other changes | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
ACPSI* 25,1633,2004
|
oral | rat
: 2,016 mg/kg/4 week- continuous
|
Biochemical: Metabolism (intermediary): Lipids including transport
|
BPBLEO 27,338,2004
|
oral | rat
: 6,048 mg/kg/12 week- continuous
|
Eye: Other eye effects
|
BPBLEO 27,338,2004
|
oral | rat
lowest published toxic dose: 1,000 mg/kg/8 day- intermittent
|
Kidney, Ureter, and Bladder: Other changes in urine composition | Kidney, Ureter, and Bladder: Other changes
TXCYAC 218,237,2006
|
oral | rat
lowest published toxic dose: 10,500 mg/kg/21 day- intermittent
|
Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi | Lung, Thorax, or Respiration: Changes in pulmonary vascular resistance Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation
TXCYAC 219,197,2006
|
oral | rat
lowest published toxic dose: 2,700 mg/kg/45 day- intermittent
|
Cardiac: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects
TXCYAC 224,128,2006
|
oral | rat
lowest published toxic dose: 1,500 mg/kg/30 day- intermittent
|
Endocrine: Change in LH | Endocrine: Change in gonadotropins Reproductive: Paternal effects: Testes, epididymis, sperm duct
TXCYAC 232,170,2007
|
oral | rat
lowest published toxic dose: 2,500 mg/kg/20 day- intermittent
|
Biochemical: Metabolism (intermediary): Other
|
NRTXDN 27,1024,2006
|
oral | rat
lowest published toxic dose: 150 mg/kg/30 day- intermittent
|
Musculoskeletal: Other changes | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases
TXCYAC 241,99,2007
|
oral | rat
lowest published toxic dose: 1,400 mg/kg/2 week- intermittent
|
Liver: Other changes | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases
IRJPH* 6,63,2007
|
oral | rat
lowest published toxic dose: 1,181.1 mg/kg/31 week- intermittent
|
Tumorigenic: Protects against induction of experimental tumors
|
JTPAE7 18,53,2005
|
oral | rat
lowest published toxic dose: 2,100 mg/kg/2 day- intermittent
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Metabolism (intermediary): Lipids including transport
SIMEJ* 46,78,2005
|
| |||
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
TOXICOLOGY REVIEW
|
|
ARPTDI 43,97,2003
|
TOXICOLOGY REVIEW
|
|
IJTOFN 21,51,2002
|
TOXICOLOGY REVIEW
|
|
TPHSDY 23,426,2002
|
TOXICOLOGY REVIEW
|
|
APHRER 39,2073,2005
|
TOXICOLOGY REVIEW
|
|
PHTOEH 93,105,2003
|
TOXICOLOGY REVIEW
|
|
ENTOX* -,449,2005
|
TOXICOLOGY REVIEW
|
|
FEREAC 73,9214,2008
|
TOXICOLOGY REVIEW
|
|
FEREAC 73,9214,2008
|
TOXICOLOGY REVIEW
|
|
FEREAC 73,9214,2008
|
TOXICOLOGY REVIEW
|
|
FEREAC 73,9214,2008
|
TOXICOLOGY REVIEW
|
|
HTOPA* 1,595,2002
|
| ||
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
| ||
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: X5582 |
Number of Industries 4; Total Number of Facilities 279; Number of Occupations 8; Total Number of Employees Exposed 6,957; Total Number of Female Employees Exposed 3,599 | |||
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
| ||
REFERENCES:
CODEN
|
|
REFERENCE
ACPSI*
|
Acta pharmacologica Sinica (Shanghai : Shanghai Institute of Materia Medica : Chinese Academy
of Science ; Carlton, VIC, Australia : Blackwell Publishing Asia, 2005) V.21- 2000-
|
APHRER
|
Annals of Pharmacotherpy. (Harvey Whitney Books Co., POB 42696, Cincinnati, OH 45242) V. 26-
1992-
|
ARPTDI
|
Annual Review of Pharmacology and Toxicology. (Annual Reviews, Inc., POB 10139, Palo Alto, CA
94303) V.16- 1976-
|
BDERE*
|
Birth Defects Research Part A, Clinical and molecular teratology (Hoboken, N.J. : John Wiley &
Sons) V.67- 2003-
|
BJMRDK
|
Brazilian Journal of Medical and Biological Research. (Associacao Brasileira de Divulgacao
Cientifica, Faculdade de Medicina de Ribeirao Preto, USP, 141000 Ribeirao Preto, SP, Brazil)
V.14- 1981-
|
BPBLEO
|
Biological and Pharmaceutical Bulletin. (Pharmaceutical Society of Japan, 2-12-15-201 Shibuya
Shibuya-ku, Tokyo 150, Japan) V.16- 1993-
|
CEXPB9
|
Clinical and Experimental Pharmacology and Physiology. (Blackwell Scientific Publications,
(Australia) Pty Ltd., 107 Barry St., Carlton, Vic. 3053, Australia) V.1- 1974-
|
CLPTAT
|
Clinical Pharmacology and Therapeutics. (American Society for Clinical Pharmacology and
Therapeutics, St. Louis Mo Mosby-Year Book) V.1- 1960-
|
CNREA8
|
Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut Sts., Philadelphia, PA
19106) V.1- 1941-
|
EJPHAZ
|
European Journal of Pharmacology. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam,
Netherlands) V.1- 1967-
|
EKFAE9
|
Eksperimental'naya i Klinicheskaya Farmakologiya. Experimental and Clinical Pharmacology.
(Mezhdunarodnaya Kniga, ul. B. Yakimanka, 39, 117049 Moscow, Russia) V.55- 1992-
|
ENTOX*
|
Encyclopedia of Toxicology: Reference Book, Elsevier, 2005
|
EXPEAM
|
Experientia. (Birkhaeuser Verlag, POB 133, CH-4010 Basel, Switzerland) V.1- 1945-
|
FATOAO
|
Farmakologiya i Toksikologiya (Moscow). For English translation, see PHTXA6 and RPTOAN. (V/O
Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1939-
|
FCLPH*
|
Fundamental & Clinical Pharmacology (Oxford : Blackwell Science) 2001-
|
FCTOD7
|
Food and Chemical Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford,
NY 10523) V.20- 1982-
|
FEREAC
|
Federal Register. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402)
V.1- 1936-
|
HTOPA*
|
|
IJTOFN
|
International Journal of Toxicology. (Taylor & Francis, 47 Runway Rd., Suite g, Levittown, PA
19057) V.16- 1997-
|
INHTE5
|
Inhalation Toxicology. (Published by Taylor & Francis Health, 11 New Fetter Lane, London EC4P
4EE) V.1- 1989-
|
IRJPH*
|
|
JAPTO*
|
Journal of Applied Toxicology (John Wiley & Sons, Ltd., Oldlands Way Bognor Regis West Sussex,
PO22 9SA England) V.1- 1981-
|
JOETD7
|
Journal of Ethnopharmacology. (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick,
Ireland) V.1- 1979-
|
JTPAE7
|
Journal of Toxicologic Pathology. (Nihon Dokusei Byori Gakkai, editor, 3-25-8 Nishi-
shinbashi, Minato-ku, Tokyo 105, Japan) V.1- 1988
|
NRTXDN
|
Neurotoxicology. (Intox Press, Inc., POB 34075, Little Rock, AR 72203) V.1- 1979-
|
NYKZAU
|
Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. (Nippon Yakuri Gakkai, c/o Kyoto
Daigaku Igakubu Yakurigaku Kyoshitsu, Konoe-cho, Yoshida, Sakyo-ku, Kyoto 606, Japan) V.40-
1944-
|
PHTOEH
|
Pharmacology and Toxicology (Copenhagen). (Munksgaard International Pub., POB 2148, DK-1016
Copenhagen K, Denmark) V.60- 1987-
|
PSCHDL
|
Psychopharmacology (Berlin). (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way,
Secaucus, NJ 07094) V.47- 1976-
|
REPTED
|
Reproductive Toxicology. (Pergamon Press Inc., Maxwell House, Fairview Park, Elmsford, NY
10523) V.1- 1987-
|
SIMEJ*
|
|
TOXID9
|
Toxicologist. (Soc. of Toxicology, Inc., 475 Wolf Ledge Parkway, Akron, OH 44311) V.1-
1981-
|
TPHSDY
|
Trends in Pharmacological Sciences. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New
York, NY 10017) V.1- 1979-
|
TXCYAC
|
Toxicology. (Elsevier Scientific Pub. Ireland, Ltd., POB 85, Limerick, Ireland) V.1- 1973-
|
| |